Literature DB >> 8554657

Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation.

T Hashimoto1, M Tayama, M Miyazaki, Y Yoneda, T Yoshimoto, M Harada, H Miyoshi, M Tanouchi, Y Kuroda.   

Abstract

Volume-selective proton magnetic resonance spectroscopy (1H-MRS) of the brain was performed with a 1.5T magnet in 28 patients with unclassified mental retardation (MR) and in 25 age-matched healthy children. Peaks of N-acetylaspartate (NAA), choline (Cho), and creatine (Cr), but not of lactate, were observed in both groups on 1H-MRS. In all our subjects of this age range, 1H-MRS revealed an increase with advancing age in the ratio of NAA/Cho (P = .0031), but no developmental change in the NAA/Cr and Cho/Cr ratios. The NAA/Cho ratio was lower in patients with MR than in controls (P = .0016). The NAA/Cr ratio tended to be lower in the MR group, and the Cho/Cr ratio did not differ between patients with MR and controls. These results suggest that in patients with MR, NAA decreases and a disorder and/or dysfunction of neurons in the brain exists.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554657     DOI: 10.1016/0887-8994(95)00159-d

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain.

Authors:  R E Jung; W M Brooks; R A Yeo; S J Chiulli; D C Weers; W L Sibbitt
Journal:  Proc Biol Sci       Date:  1999-07-07       Impact factor: 5.349

Review 2.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

3.  Proton magnetic resonance spectroscopy in developmentally delayed young boys with or without autism.

Authors:  M Zeegers; J van der Grond; E van Daalen; J Buitelaar; H van Engeland
Journal:  J Neural Transm (Vienna)       Date:  2006-05-24       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.